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43.7% resistant) and erythromycin (9% intermediate and
75% resistant) respectively. MIC 90 of penicillin and ery-
thromycin were 2mg/liter and >128mg/liter. 75% of the
isolates showed multipdrug resistance.
PCR results showed 95% of the strains had at least one
altered pbp in which 82% had all 3 altered pbps, 89% had
macrolide resistance genes erm(B) and/or mef(A), 73% con-
tained erm (B) gene, 17% contained both mef(A)and erm(B).
Conclusion: Penicillin and macrolide resistances among
pneumococcal isolates have been increasing in the Northern
part of Vietnam with an alarming level of macrolide resis-
tance. Erm(B) mediated mechanism was predominant with a
high level resistance in the region. This study emphasizes the
need to have an active and larger laboratory-based surveil-
lance for monitoring antibiotic resistance of pneumococci
and other respiratory pathogens in Vietnam.
doi:10.1016/j.ijid.2008.05.741
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Background: The increasing temporal trend of antimi-
crobial resistance among Gram-positive cocci (including
Enterococci) is of concern, especially among inpatients.
Materials and Methods: The temporal trend of the in vitro
antibiotic susceptibility rates was examined for all Entero-
coccus faecalis and Enterococcus faecium strains, isolated at
our General Teaching Hospital during the years 2004—2007.
The same pathogen isolated more than once from the same
patient within one month, has been considered once.
Results: Among Enterococcus faecalis isolates (2,736
strains tested on the whole), the greater activity rate
was achieved by linezolid (100% of tested strains),
followed by teicoplanin (97.9—100% of strains), nitrofu-
rantoin (96.4—98.3%), vancomycin (81.0—100%), ampicillin
(90.2—91.9%), penicillin (88.8—91.5%), while irregular vari-
ations of sensitivity occurred over time for gentamicin
(>60% of tested strains), streptomycin (>70% of strains),
and tetracyclines (<20% of strains). When considering
Enterococcus faecium strains (626 overall isolates), only
linezolid maintained a 100% in vitro activity, followed
by teicoplanin (87.7—100% of tested strains), vancomycin
(78.4—86.2% of strains), tetracyclines (56.8-81%), and gen-
tamicin (59.1—71.0%), while unpredictable efﬁcacy was
shown by streptomycin (27.6—69.8% of tested strains). Sixty-
six strains of vancomycin-resistant Enterococcal strains were
detected, with a clearly increased trend from 2004 (7 cases)
to 2007 (21 cases) (p < .001). An increased in vitro resis-
tance rate was also detected for tetracyclines, during the
four-year study period (p < .01).
Conclusions: A prospective surveillance monitoring of the
in vitro antimicrobial sensitivity ﬁgures of Enterococci as
relevant hospital pathogens, plays an useful role to tar-
get antimicrobial treatment and prophylaxis strategies, on
local and regional basis. The emerging of resistance to
the reference compounds, and that of vancomycin-resistant
organisms in particular, may be also well assessed on these
temporal basis, in order to addresss the clinical choice
according to the local epidemiology and antimicrobial test-
ing features.
doi:10.1016/j.ijid.2008.05.742
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Background: The incidence of systemic fungal infections
caused by non-albicans species is increasing. Colonization
with Candida has been identiﬁed as an independent risk
factor for invasive Candidiasis.
Methods: In a prospective study for 30 month, we anal-
ysed samples weekly over a period of four weeks from an
initial count of 411 patients (mean APACHE-II-Score 20.8)
admitted to our ICU. Swabs from nostril, throat and anus
and specimens of tracheal secretions and urine were taken
and cultured on CHROM- or CandID- Agar at 36 ◦C.
Results: 41 of the patients in the study stayed in the ICU
for at least 4 weeks. Of these, 24 received systemic antimy-
cotics (mean duration 15.9 days) for proven or probable
fungal infection. In the untreated group, Candida species
were cultured from 29% of specimens at baseline (71% Can-
dida albicans, 13% Candida glabrata, 17% Candida tropicalis,
4% Candida parapsilosis, 0% Candida krusei) and in 42% after
4 weeks (66% Candida albicans, 16% Candida glabrata, 0%
Candida tropicalis, 16% Candida parapsilosis, 0% Candida
krusei). In the group with systemic antimycotic therapy,
Candida species were cultured from 66% of specimens at
baseline (59% Candida albicans, 46% Candida glabrata, 6%
Candida tropicalis, 3% Candida parapsilosis, 11% Candida
krusei) and in 39% after 4 weeks (29% Candida albicans,
60% Candida glabrata, 0% Candida tropicalis, 13% Candida
parapsilosis, 7% Candida krusei).
Conclusions: Antimycotic therapy results in a reduction in
Candida colonization. This is due to a decrease in the frac-
tion of Candida albicans whereas Candida glabrata is left
unchanged. In the absence of antimycotics, Candida colo-
nization increase and the fractions of Candida albicans and
Candida glabrata remain unchanged.
doi:10.1016/j.ijid.2008.05.743
